Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
作者信息
Adabag A Selcuk, Maron Barry J
机构信息
Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, MN 55417, USA.
出版信息
Ann Noninvasive Electrocardiol. 2007 Apr;12(2):171-80. doi: 10.1111/j.1542-474X.2007.00157.x.
Abstract
摘要
相似文献
1
Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
Ann Noninvasive Electrocardiol. 2007 Apr;12(2):171-80. doi: 10.1111/j.1542-474X.2007.00157.x.
2
[Therapy of hypertrophic cardiomyopathy].
G Ital Cardiol. 1999 Oct;29(10):1199-203.
3
Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:37-49.
4
Sudden death due to cardiac arrhythmias.
N Engl J Med. 2001 Nov 15;345(20):1473-82. doi: 10.1056/NEJMra000650.
5
Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Heart. 2014 Feb;100(3):254-60. doi: 10.1136/heartjnl-2012-301996. Epub 2013 Apr 10.
6
Sudden death in nondilated cardiomyopathies: pathophysiology and prevention.
Curr Heart Fail Rep. 2005 Sep;2(3):118-23. doi: 10.1007/s11897-005-0019-x.
7
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
Circulation. 2003 Jun 17;107(23):2872-5. doi: 10.1161/01.CIR.0000072343.81530.75.
8
Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
Fundam Clin Pharmacol. 2010 Oct;24(5):637-52. doi: 10.1111/j.1472-8206.2010.00869.x. Epub 2010 Aug 19.
9
[Primary and secondary prevention of sudden cardiac death].
Pol Arch Med Wewn. 2006 Jan;115(1):65-72.
10
[Clinical therapy for arrhythmias and EBM].
Nihon Naika Gakkai Zasshi. 2006 Feb 10;95(2):234-9. doi: 10.2169/naika.95.234.
引用本文的文献
1
The Unseen Side of Feline Hypertrophic Cardiomyopathy: Diagnostic and Prognostic Utility of Electrocardiography and Holter Monitoring.
Animals (Basel). 2024 Jul 25;14(15):2165. doi: 10.3390/ani14152165.
2
Antiarrhythmic effects of metformin.
Heart Rhythm O2. 2024 Apr 11;5(5):310-320. doi: 10.1016/j.hroo.2024.04.003. eCollection 2024 May.
3
Perioperative changes in left ventricular systolic function following surgical revascularization.
PLoS One. 2022 Nov 10;17(11):e0277454. doi: 10.1371/journal.pone.0277454. eCollection 2022.
4
Arrhythmic causes of in-hospital cardiac arrest among patients with heart failure with preserved ejection fraction.
Heart Rhythm O2. 2021 Nov 2;2(6Part A):665-667. doi: 10.1016/j.hroo.2021.10.007. eCollection 2021 Dec.
5
Predictors of Sudden Cardiac Arrest Among Patients With Post-Myocardial Infarction Ejection Fraction Greater Than 35.
J Am Heart Assoc. 2021 Jul 20;10(14):e020993. doi: 10.1161/JAHA.121.020993. Epub 2021 Jul 14.
6
Synchronous cardiac arrest in monozygotic twins with hypertrophic cardiomyopathy--is sudden cardiac death genetically pre-programmed?
BMC Cardiovasc Disord. 2015 Feb 28;15:16. doi: 10.1186/s12872-015-0007-3.
7
A primer on arrhythmias in patients with hypertrophic cardiomyopathy.
Curr Cardiol Rep. 2012 Oct;14(5):552-62. doi: 10.1007/s11886-012-0297-3.
8
Hypertrophic cardiomyopathy and sudden cardiac death.
World J Cardiol. 2010 Sep 26;2(9):289-98. doi: 10.4330/wjc.v2.i9.289.
9
Sudden death in hypertrophic cardiomyopathy.
J Cardiovasc Transl Res. 2009 Dec;2(4):368-80. doi: 10.1007/s12265-009-9147-0. Epub 2009 Nov 13.
10
Hypertrophic cardiomyopathy as a cause of sudden death.
Herz. 2009 Jun;34(4):305-14. doi: 10.1007/s00059-009-3248-z.
本文引用的文献
1
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
Circulation. 2006 Jul 18;114(3):216-25. doi: 10.1161/CIRCULATIONAHA.105.583500. Epub 2006 Jul 10.
2
Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?
Am J Cardiol. 2006 Apr 15;97(8):1255-61. doi: 10.1016/j.amjcard.2005.11.048. Epub 2006 Mar 9.
3
Identical twins with hypertrophic cardiomyopathy and apical aneurysm.
Am J Cardiol. 2006 Apr 1;97(7):1109. doi: 10.1016/j.amjcard.2005.10.059. Epub 2006 Feb 24.
4
Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.
Ann Noninvasive Electrocardiol. 2005 Oct;10(4 Suppl):67-83. doi: 10.1111/j.1542-474X.2005.00070.x.
5
Lessons from the failure and recall of an implantable cardioverter-defibrillator.
Circulation. 2005 Sep 27;112(13):2040-2. doi: 10.1161/CIRCULATIONAHA.105.580381. Epub 2005 Sep 19.
6
Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
Circulation. 2005 Aug 9;112(6):855-61. doi: 10.1161/CIRCULATIONAHA.104.507723.
7
Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy.
Heart Rhythm. 2005 Aug;2(8):814-9. doi: 10.1016/j.hrthm.2005.05.008.
8
Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy.
Heart Rhythm. 2005 Jul;2(7):681-3. doi: 10.1016/j.hrthm.2005.05.014.
9
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2005 Apr 19;45(8):1251-8. doi: 10.1016/j.jacc.2005.01.012.
10
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2005 Mar 1;45(5):697-704. doi: 10.1016/j.jacc.2004.11.043.
Zotero 插件